20 (AIDX) Treasury Shares (2024 - 2026)

20 (AIDX) posted Treasury Shares of $3.7 million for Q1 2026, up 24119.48% on a QoQ basis from $15096.0 in Q4 2024.

20 (AIDX) Treasury Shares (2024 - 2026) Analysis & Trends

20's Treasury Shares history runs 2 years deep, the most recent figure standing at $3.7 million for Q1 2026.

Quarterly Treasury Shares changed N/A year-over-year to $3.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.7 million (changed N/A YoY) and the FY2025 annual result came in at $64966.0, up 330.35% from the prior year.
Treasury Shares was $3.7 million for Q1 2026 at 20, up from $15096.0 in the prior quarter.
Across five years, Treasury Shares topped out at $3.7 million in Q1 2026 and bottomed at $15096.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	16.94 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	-
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	7.70 Mn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	263.29 Mn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	83.00 Mn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	2.12 Bn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	14.05 Mn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	4.51 Mn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	515.00 Mn
10	20	3.91 Mn	-313,912.28	62,884.00	3.66 Mn

Download Data